These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25491208)

  • 21. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
    Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
    Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New understanding and approaches to treatment in rheumatoid arthritis.
    Tayar JH; Suarez-Almazor ME
    Br Med Bull; 2010; 94():201-14. PubMed ID: 20200013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.
    Gorter SL; Bijlsma JW; Cutolo M; Gomez-Reino J; Kouloumas M; Smolen JS; Landewé R
    Ann Rheum Dis; 2010 Jun; 69(6):1010-4. PubMed ID: 20448288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survey of the therapeutic management of rheumatoid arthritis in France: the OPALE study.
    Saraux A; Combe B; Blin P; Bregman B; Chartier M; Durieux-Mehlman S; Guillemin F
    Clin Exp Rheumatol; 2010; 28(3):325-32. PubMed ID: 20460034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
    Gibofsky A; Palmer WR; Goldman JA; Lautzenheiser RL; Markenson JA; Weaver A; Schiff MH; Keystone EC; Paulus HE; Harrison MJ; Whitmore JB; Leff JA
    Curr Med Res Opin; 2006 Jan; 22(1):169-83. PubMed ID: 16393443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rheumatoid arthritis patients fulfilling Korean National Health Insurance reimbursement guidelines for anti-tumor necrosis factor-α treatment and comparison to other guidelines.
    Hur JW; Choe JY; Kim DW; Kim HA; Kim SH; Kim WU; Kim YS; Lee HS; Lee SH; Park SH; Park W; Park YB; Suh CH; Shim SC; Song YW; Yoon BY; Yu DY; Yoo DH
    Rheumatol Int; 2015 Nov; 35(11):1817-23. PubMed ID: 26342296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of early rheumatoid arthritis in a multinational inception cohort of Latin American patients: the GLADAR experience.
    Cardiel MH; Pons-Estel BA; Sacnun MP; Wojdyla D; Saurit V; Marcos JC; Pinto MR; Cordeiro de Azevedo AB; da Silveira IG; Radominski SC; Ximenes AC; Massardo L; Ballesteros F; Rojas-Villarraga A; Oñate RV; Hernandez MP; Esquivel-Valerio JA; García-De La Torre I; Khoury VJ; Millán A; Soriano ER;
    J Clin Rheumatol; 2012 Oct; 18(7):327-35. PubMed ID: 23047532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TNF inhibitors for rheumatoid arthritis - a year in review.
    Simsek I
    Bull NYU Hosp Jt Dis; 2011; 69(3):220-4. PubMed ID: 22035432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gap Between Official Guidelines and Clinical Practice for the Treatment of Rheumatoid Arthritis in São Paulo, Brazil.
    de Camargo IA; Almeida Barros BC; do Nascimento Silveira MS; Osorio-de-Castro CG; Guyatt G; Lopes LC
    Clin Ther; 2016 May; 38(5):1122-33. PubMed ID: 26976223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Differences in the management of early and established rheumatoid arthritis].
    Castañeda S; Navarro F; Fernández-Carballido C; Tornero C; Marced E; Corteguera M
    Reumatol Clin; 2011; 7(3):172-8. PubMed ID: 21794809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.
    Bykerk VP; Akhavan P; Hazlewood GS; Schieir O; Dooley A; Haraoui B; Khraishi M; Leclercq SA; Légaré J; Mosher DP; Pencharz J; Pope JE; Thomson J; Thorne C; Zummer M; Bombardier C;
    J Rheumatol; 2012 Aug; 39(8):1559-82. PubMed ID: 21921096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of patients with rheumatoid arthritis in Latin America: a consensus position paper from Pan-American League of Associations of Rheumatology and Grupo Latino Americano De Estudio De Artritis Reumatoide.
    Massardo L; Suárez-Almazor ME; Cardiel MH; Nava A; Levy RA; Laurindo I; Soriano ER; Acevedo-Vázquez E; Millán A; Pineda-Villaseñor C; Galarza-Maldonado C; Caballero-Uribe CV; Espinosa-Morales R; Pons-Estel BA
    J Clin Rheumatol; 2009 Jun; 15(4):203-10. PubMed ID: 19502907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UK consultant rheumatologists' access to biological agents and views on the BSR Biologics Register.
    Kay LJ; Griffiths ID;
    Rheumatology (Oxford); 2006 Nov; 45(11):1376-9. PubMed ID: 17040892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hand and foot surgery rates in rheumatoid arthritis have declined from 1986 to 2011, but large-joint replacement rates remain unchanged: results from two UK inception cohorts.
    Nikiphorou E; Carpenter L; Morris S; Macgregor AJ; Dixey J; Kiely P; James DW; Walsh DA; Norton S; Young A
    Arthritis Rheumatol; 2014 May; 66(5):1081-9. PubMed ID: 24782174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Alternatives in the treatment of rheumatoid arthritis: reasons for using abatacept].
    Castañeda S; Martínez Calatrava MJ; Herrero-Beaumont G
    Rev Clin Esp; 2012 May; 212(5):244-54. PubMed ID: 22176928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Healthcare research in rheumatology. Current state].
    Zink A
    Z Rheumatol; 2014 Mar; 73(2):115-22. PubMed ID: 24549920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical profile of 266 Filipino patients with rheumatoid arthritis included in the rheumatoid arthritis database and registry (RADAR) of the Philippine General Hospital.
    Penserga EG; Natividad TA; Salido ES;
    Int J Rheum Dis; 2015 May; 18(4):433-8. PubMed ID: 26010598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment and management of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wide difference in biologics usage and expenditure for the treatment of patients with rheumatoid arthritis in each prefecture in Japan analyzed using "National Database of Health Insurance Claims and Specific Health Checkups of Japan".
    Kamata Y; Minota S
    Rheumatol Int; 2018 Apr; 38(4):663-668. PubMed ID: 29204683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on the prevalence and incidence of rheumatoid arthritis in Korea and an analysis of medical care and drug utilization.
    Won S; Cho SK; Kim D; Han M; Lee J; Jang EJ; Sung YK; Bae SC
    Rheumatol Int; 2018 Apr; 38(4):649-656. PubMed ID: 29302803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.